CCS Surge Confirms AI Demand, Risks Linger

What happened

A Zacks article highlights that Celestica's Connectivity & Cloud Solutions (CCS) segment continues to ride strong AI networking demand, with revenues jumping 76% driven by hyperscaler deployments and next-gen compute program ramps. This aligns with the company's Q1 2026 results, where CCS revenue grew 53% YoY and segment margin improved to 8.6%. However, the DeepValue report maintains a WAIT rating, noting that the stock at $361.50 already prices in sustained hyperscaler AI infrastructure deployments and a $1.0B capacity ramp. Key risks remain: extreme customer concentration (35%/15%/15%) and potential utility/grid interconnection bottlenecks that could cause a utilization-driven earnings air pocket during peak capex. The article does not address these risks, so the fundamental thesis of waiting for evidence of stable CCS margins and improving cash conversion remains intact.

Implication

For investors, the Zacks article reinforces that CCS momentum is real and driven by hyperscaler AI investment, which supports the bull case. However, the DeepValue report's WAIT rating remains appropriate because the valuation (P/E 43x) already embeds this strength. The primary risks—a 35% customer concentration and the $1B capex ramp depending on utility/grid timelines—are unaddressed in the article. Short-term traders may see continued momentum, but long-term investors should wait for evidence that CCS margins remain stable above 8.5% and that working capital normalizes (A/R sales decline from $314M). The attractive entry point per DeepValue is $300, offering a 17% downside from current levels, while a trim above $420 suggests limited upside without de-risking. Until the next quarterly filing shows no program delays or margin compression, the risk/reward skews negative.

Thesis delta

The news reaffirms strong CCS demand and operating leverage, consistent with the bull scenario in the DeepValue report. However, it does not alter the core thesis that waiting for proof of stable margins and cash conversion is prudent. The thesis remains WAIT with no change in conviction.